cTAPcTAPcTAPcTAP
  • WHAT WE DO
  • HOW WE DO IT
    • Our Leadership
    • OUR SCIENTIFIC ADVISORS
    • Our Approach
  • OUR PROGRAMS
    • cTAP DUCHENNE
    • What’s Next
  • OUR IMPACT
    • Publications
    • Abstracts
    • News & Press
    • Presentations
  • PARTNER WITH US
    • Patient Organizations
    • Scientific Leaders & Researchers
    • Industry
  • CONTACT

Press release: cTAP Study Indicates DMD Clinical Trial Enrollment Criteria Should Expand Beyond Ambulatory Status

Home / Blog / News & Press / Press release: cTAP Study Indicates DMD Clinical Trial Enrollment Criteria Should Expand Beyond Ambulatory Status

Minimal detectable changes in functional measures in Duchenne muscular dystrophy: a study of multiple centers, networks and trial arms
New study may help more DMD patients be included in clinical trials

Press release: cTAP Study Indicates DMD Clinical Trial Enrollment Criteria Should Expand Beyond Ambulatory Status

Jul 24, 2024 – Study co-funded by cTAP and CureDuchenne highlights the need for more specific enrollment criteria that could increase patient participation and drive more comprehensive therapeutic evaluation.

Read the full press release on PR Newswire

Read the full scientific article in PLoS ONE

15
Aug 2024
By SC-admin-313News & PressComments Off on Press release: cTAP Study Indicates DMD Clinical Trial Enrollment Criteria Should Expand Beyond Ambulatory Status

Read the latest

  • Predicting multi-year changes in rise-from-floor (RFF) Velocity in Duchenne muscular dystrophy
  • A prognostic score for time to loss of hand-to-mouth ability in Duchenne muscular dystrophy
  • Functional Assessments Used in Routine Care for Duchenne Muscular Dystrophy in the United States: A Survey of Certified Duchenne Care Centers
  • cTAP Announces Novel Prognostic Score Developed for Duchenne Muscular Dystrophy Patients Offers Improved Prediction of Loss of Ambulation
  • A Prognostic Score for Time to Loss of Hand-to-Mouth Ability in Duchenne Muscular Dystrophy (DMD)

COLLABORATIVE TRAJECTORY
ANALYSIS PROJECT

501 (c) 3 nonprofit organization

Cambridge Innovative Center
One Broadway, Cambridge, MA 02142

T: 617-555-5555
E: info@ctap-nmd.org

Terms & Conditions
Privacy Policy

© 2026 Collaborative Trajectory Analysis Project. All rights reserved.

  • WHAT WE DO
  • HOW WE DO IT
    • Our Leadership
    • OUR SCIENTIFIC ADVISORS
    • Our Approach
  • OUR PROGRAMS
    • cTAP DUCHENNE
    • What’s Next
  • OUR IMPACT
    • Publications
    • Abstracts
    • News & Press
    • Presentations
  • PARTNER WITH US
    • Patient Organizations
    • Scientific Leaders & Researchers
    • Industry
  • CONTACT

Terms and Conditions - Privacy Policy